Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients

21 Feb 2025

Abstract excerpt

Background/Objectives: The COVID-19 pandemic resulted in 675 million cases and 6.9 million deaths by 2022. Despite substantial declines in case fatalities following widespread vaccination campaigns, the threat of future coronavirus outbreaks remains a concern. Current treatments for COVID-19 have been repurposed from existing therapies for other infectious and non-infectious diseases. Emerging evidence suggests a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Drug-Induced Hepatotoxicity and Protection
Share to Inflammasome and immune disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40149530
DOI: 10.3390/biomedicines13030553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 PatientsPMID 40149530Read ↗

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approachesSemantic proximity Read ↗

Interplay between demographic, clinical and polygenic risk factors for severe COVID-19Semantic proximity Read ↗

IDENTIFICATION OF HUMAN GENETIC VARIANTS MODULATING THE COURSE OF COVID-19 INFECTIONSemantic proximity Read ↗

Genetic risk factors and Covid-19 severity in Brazil: results from BRACOVID StudySemantic proximity Read ↗

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read ↗

An integrative multiomics analysis identifies putative causal genes for COVID-19 severity.Semantic proximity Read ↗

Multi-ancestry omic Mendelian randomization revealing putative drug targets of COVID-19 severitySemantic proximity Read ↗

Multi-Ancestry Mendelian Randomization of Omics Traits Revealing Putative Drug Targets of COVID-19 SeveritySemantic proximity Read ↗

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read ↗

ACE2, TMPRSS2, and TLR8 single-nucleotide polymorphisms are associated with a high risk of severe COVID-19 disease and deathSemantic proximity Read ↗

Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19.Semantic proximity Read ↗

Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.